152
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Evaluation of reference intervals for biomarkers sensitive to alcohol consumption, excess body weight and oxidative stress

, , , &
Pages 104-111 | Received 10 Sep 2009, Accepted 07 Dec 2009, Published online: 14 Jan 2010

References

  • Europe in figures – Eurostat yearbook 2008. Luxembourg: Office for Official Publications of the European Communities 2008 (ISBN 978-92-79-06607-8).
  • Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 2006;367:52–6.
  • Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995;333:1058–65.
  • Ramstedt M. Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. Addiction 2001;96 (Suppl. 1):S19–S33.
  • Rustad P. Nordic Reference Interval Project. http://www.furst.no/norip/.
  • Lahti A. Are the common reference intervals truly common? Case studies on stratifying biochemical reference data by countries using two partitioning methods. Scand J Clin Lab Invest 2004;64:407–30.
  • Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Martensson A, Hyltoft PP, Simonsson P, Steensland H, Uldall A. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest 2004;64:271–84.
  • Felding P, Rustad P, Mårtensson A, Kairisto V, Franzson L, Hyltoft PP, Uldall A. Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004;64:327–42.
  • Solberg HE. Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987;25:645–56.
  • Rustad P, Felding P, Lahti A, Hyltoft PP. Descriptive analytical data and consequences for calculation of common reference intervals in the Nordic Reference Interval Project 2000. Scand J Clin Lab Invest 2004;64:343–70.
  • Sillanaukee P, Kiianmaa K, Roine R, Seppä K. Alkoholin suurkulutuksen kriteerit [Criteria of heavy drinking]. Suom Lääkäril 1992;31:2919–21.
  • Mukamal KJ, Rimm EB. Alcohol consumption: risks and benefits. Curr Atheroscler Rep 2008;10:536–43.
  • Tolstrup JS, Gronbaek M, Tybjaerg-Hansen A, Nordestgaard BG. Alcohol intake, alcohol dehydrogenase genotypes, and liver damage and disease in the Danish general population. Am J Gastroenterol 2009;104:2182–8.
  • Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000;342:1266–71.
  • Hietala J, Koivisto H, Anttila P, Niemelä O. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2006;41:528–33.
  • Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202–19.
  • Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467–74.
  • Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413–9.
  • Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005;42:650–6.
  • Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286–92.
  • Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960–7.
  • Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 2002;50:585–8.
  • McNair A. Non-alcoholic steatohepatitis (NASH): why biopsy? Gut 2002;51:898–9.
  • Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 2008;47:1363–70.
  • Monami M, Bardini G, Lamanna C, Pala L, Cresci B, Fran-cesconi P, Buiatti E, Rotella CM, Mannucci E. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study. Metabolism 2008;57:387–92.
  • Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130–7.
  • Goessling W, Massaro JM, Vasan RS, D’Agostino RB, Sr., Ellison RC, Fox CS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008;135:1935–44.
  • Ioannou GN. Implications of elevated serum alanine aminotransferase levels: think outside the liver. Gastroenterology 2008;135:1851–4.
  • Day CP, James OF. Steatohepatitis: a tale of two ‘hits’? Gastroenterology 1998;114:842–5.
  • Carmiel-Haggai M, Cederbaum AI, Nieto N. Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 2003;125:1818–33.
  • Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705–12.
  • Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004;44:275–95.
  • Caro AA, Cederbaum AI. Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 2004;44:27–42.
  • Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu RS, Niemelä OJ. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 2008;88:1097–103.
  • Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263–355.
  • Alatalo PI, Koivisto HM, Hietala JP, Bloigu RS, Niemelä OJ. Gender-dependent impacts of body mass index and moderate alcohol consumption on serum uric acid – an index of oxidant stress status? Free Radic Biol Med 2009;46:1233–8.
  • Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 2007;17:409–14.
  • Li JM, Mukamal KJ. An update on alcohol and atherosclerosis. Curr Opin Lipidol 2004;15:673–80.
  • Sesso HD. Alcohol and cardiovascular health: recent findings. Am J Cardiovasc Drugs 2001;1:167–72.
  • Breitling LP, Raum E, Muller H, Rothenbacher D, Brenner H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009;49:802–8.
  • Strømme JH, Rustad P, Steensland H, Theodorsen L, Urdal P. Reference intervals for eight enzymes in blood of adult females and males measured in accordance with the International Federation of Clinical Chemistry reference system at 37 degrees C: part of the Nordic Reference Interval Project. Scand J Clin Lab Invest 2004;64:371–84.
  • Rustad P, Hyltoft PP. Effect of analytical quality on establishing common reference intervals and their use. Scand J Clin Lab Invest 2004;64:399–406.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.